Skip to main content
Erschienen in: Osteoporosis International 5/2003

01.09.2003 | Original Article

Bone strength in primary hyperparathyroidism

verfasst von: John P. Bilezikian

Erschienen in: Osteoporosis International | Sonderheft 5/2003

Einloggen, um Zugang zu erhalten

Excerpt

This conference is focusing on bone strength and the factors that account for it. Quite correctly, the disease process with which it is most concerned is postmenopausal osteoporosis (PMO) because it is the most important metabolic bone disease. However, insights can be gained by considering the matter of bone strength in other diseases. This paper focuses upon primary hyperparathyroidism, another common metabolic bone disease. Insights gained from a consideration of bone strength in primary hyperparathyroidism are of interest for their relevance to the disease itself as well as to how understanding issues of bone strength in a disorder of chronic parathyroid hormone (PTH) excess might be relevant to understanding how the use of intermittent PTH improves bone strength in PMO. …
Literatur
1.
Zurück zum Zitat Proceedings of the NIH Consensus Development Conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Bethesda, Maryland, October 29–31, 1990 (1991) J Bone Miner Res 6 [Suppl 2]:S1–166 Proceedings of the NIH Consensus Development Conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Bethesda, Maryland, October 29–31, 1990 (1991) J Bone Miner Res 6 [Suppl 2]:S1–166
2.
Zurück zum Zitat Khosla S, Melton LJ 3rd, Wermers RA, et al (1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14:1700–1707PubMed Khosla S, Melton LJ 3rd, Wermers RA, et al (1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14:1700–1707PubMed
3.
Zurück zum Zitat Silverberg SJ, Locker FG, Bilezikian JP (1996) Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81:4007–4012 Silverberg SJ, Locker FG, Bilezikian JP (1996) Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81:4007–4012
4.
Zurück zum Zitat Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249–1255CrossRefPubMed Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249–1255CrossRefPubMed
5.
Zurück zum Zitat Parisien M, Dempster DW, Shane E, Bilezikian JP (2001) Histomorphometric analysis of bone in primary hyperparathyroidism. In: Levine MA (ed) The parathyroids. Academic Press, San Diego, pp 423–436 Parisien M, Dempster DW, Shane E, Bilezikian JP (2001) Histomorphometric analysis of bone in primary hyperparathyroidism. In: Levine MA (ed) The parathyroids. Academic Press, San Diego, pp 423–436
6.
Zurück zum Zitat Dempster DW, Caldwell NJ, Goldstein SA, et al (2002) Three dimensional assessment of trabecular architecture in mild primary hyperparathyroidism. J Bone Miner Res 17 [Suppl 1]:1173a Dempster DW, Caldwell NJ, Goldstein SA, et al (2002) Three dimensional assessment of trabecular architecture in mild primary hyperparathyroidism. J Bone Miner Res 17 [Suppl 1]:1173a
7.
Zurück zum Zitat Seeman E (2001) Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 86:4576–4584 Seeman E (2001) Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab 86:4576–4584
8.
Zurück zum Zitat Adami S, Braga V, Squaranti R, et al (1998) Bone measurements in asymptomatic primary hyperparathyroidism. Bone 22:565–570CrossRefPubMed Adami S, Braga V, Squaranti R, et al (1998) Bone measurements in asymptomatic primary hyperparathyroidism. Bone 22:565–570CrossRefPubMed
9.
Zurück zum Zitat Parfitt AM (2002) Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 17:1741–1743PubMed Parfitt AM (2002) Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 17:1741–1743PubMed
10.
Zurück zum Zitat Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM (1988) Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67:1294–1298 Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM (1988) Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67:1294–1298
11.
Zurück zum Zitat Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Heath H 3rd (1992) Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 152:2269–2273CrossRefPubMed Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Heath H 3rd (1992) Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 152:2269–2273CrossRefPubMed
12.
Zurück zum Zitat Silverberg SJ, Bilezikian JP (2002) "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease? J Bone Miner Res 17 [Suppl]:165 Silverberg SJ, Bilezikian JP (2002) "Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease? J Bone Miner Res 17 [Suppl]:165
Metadaten
Titel
Bone strength in primary hyperparathyroidism
verfasst von
John P. Bilezikian
Publikationsdatum
01.09.2003
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe Sonderheft 5/2003
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-003-1482-4

Weitere Artikel der Sonderheft 5/2003

Osteoporosis International 5/2003 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.